HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness

Ana Paula Souza, Caroline Albuquerque, Carolina Torronteguy, Antonio Frasson, Fabio Maito, Luciana Pereira, Vinicius Duval Da Silva, Felipe Zerwes, Deborah Raynes, Vincent Guerriero, Cristina Bonorino

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

HspBP1 is a co-chaperone that binds to and regulates the chaperone Hsp70 (Hsp70 is used to refer to HSPA1A and HSPA1B). Hsp70 is known to be elevated in breast tumor tissue, therefore the purpose of these studies was to quantify the expression of HspBP1 in primary breast tumors and in serum of these patients with a follow-up analysis after 6 to 7 years. Levels of HspBP1, Hsp70, and anti-HspBP1 antibodies in sera of breast cancer patients and healthy individuals were measured by enzyme-linked immunosorbent assay. Expression of HspBP1 was quantified from biopsies of tumor and normal breast tissue by Western blot analysis. The data obtained were analyzed for association with tumor aggressiveness markers and with patient outcome. The levels of HspBP1 and Hsp70 were significantly higher in sera of patients compared to sera of healthy individuals. HspBP1 antibodies did not differ significantly between groups. HspBP1 levels were significantly higher in tumor (14.46 ng/μg protein, n=51) compared to normal adjacent tissue (3.17 ng/μg protein, n= 41, p<0.001). Expression of HspBP1 was significantly lower in patients with lymph node metastasis and positive for estrogen receptora. HspBP1 levels were also significantly lower in patients with a higher incidence of metastasis and death following a 6 to 7-year follow-up. The HspBP1/Hsp70 molar ratio was not associated with the prognostic markers analyzed. Our results indicate that low HspBP1 expression could be a candidate tumor aggressiveness marker.

Original languageEnglish (US)
Pages (from-to)301-310
Number of pages10
JournalCell Stress and Chaperones
Volume14
Issue number3
DOIs
StatePublished - May 2009

Fingerprint

Tumors
Tissue
Breast Neoplasms
Tumor Biomarkers
Neoplasms
Serum
Immunosorbents
Biopsy
Neoplasm Metastasis
Anti-Idiotypic Antibodies
Assays
Estrogens
Proteins
Association reactions
Antibodies
Enzymes
Lymph Nodes
Western Blotting
Enzyme-Linked Immunosorbent Assay
Incidence

Keywords

  • Breast cancer
  • Co-chaperone
  • Hsp70
  • Hspbp1
  • Prognostic markers

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Souza, A. P., Albuquerque, C., Torronteguy, C., Frasson, A., Maito, F., Pereira, L., ... Bonorino, C. (2009). HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness. Cell Stress and Chaperones, 14(3), 301-310. https://doi.org/10.1007/s12192-008-0085-6

HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness. / Souza, Ana Paula; Albuquerque, Caroline; Torronteguy, Carolina; Frasson, Antonio; Maito, Fabio; Pereira, Luciana; Da Silva, Vinicius Duval; Zerwes, Felipe; Raynes, Deborah; Guerriero, Vincent; Bonorino, Cristina.

In: Cell Stress and Chaperones, Vol. 14, No. 3, 05.2009, p. 301-310.

Research output: Contribution to journalArticle

Souza, AP, Albuquerque, C, Torronteguy, C, Frasson, A, Maito, F, Pereira, L, Da Silva, VD, Zerwes, F, Raynes, D, Guerriero, V & Bonorino, C 2009, 'HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness', Cell Stress and Chaperones, vol. 14, no. 3, pp. 301-310. https://doi.org/10.1007/s12192-008-0085-6
Souza, Ana Paula ; Albuquerque, Caroline ; Torronteguy, Carolina ; Frasson, Antonio ; Maito, Fabio ; Pereira, Luciana ; Da Silva, Vinicius Duval ; Zerwes, Felipe ; Raynes, Deborah ; Guerriero, Vincent ; Bonorino, Cristina. / HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness. In: Cell Stress and Chaperones. 2009 ; Vol. 14, No. 3. pp. 301-310.
@article{9d6fcbafa2114ec48aa0b6c5c3562e0f,
title = "HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness",
abstract = "HspBP1 is a co-chaperone that binds to and regulates the chaperone Hsp70 (Hsp70 is used to refer to HSPA1A and HSPA1B). Hsp70 is known to be elevated in breast tumor tissue, therefore the purpose of these studies was to quantify the expression of HspBP1 in primary breast tumors and in serum of these patients with a follow-up analysis after 6 to 7 years. Levels of HspBP1, Hsp70, and anti-HspBP1 antibodies in sera of breast cancer patients and healthy individuals were measured by enzyme-linked immunosorbent assay. Expression of HspBP1 was quantified from biopsies of tumor and normal breast tissue by Western blot analysis. The data obtained were analyzed for association with tumor aggressiveness markers and with patient outcome. The levels of HspBP1 and Hsp70 were significantly higher in sera of patients compared to sera of healthy individuals. HspBP1 antibodies did not differ significantly between groups. HspBP1 levels were significantly higher in tumor (14.46 ng/μg protein, n=51) compared to normal adjacent tissue (3.17 ng/μg protein, n= 41, p<0.001). Expression of HspBP1 was significantly lower in patients with lymph node metastasis and positive for estrogen receptora. HspBP1 levels were also significantly lower in patients with a higher incidence of metastasis and death following a 6 to 7-year follow-up. The HspBP1/Hsp70 molar ratio was not associated with the prognostic markers analyzed. Our results indicate that low HspBP1 expression could be a candidate tumor aggressiveness marker.",
keywords = "Breast cancer, Co-chaperone, Hsp70, Hspbp1, Prognostic markers",
author = "Souza, {Ana Paula} and Caroline Albuquerque and Carolina Torronteguy and Antonio Frasson and Fabio Maito and Luciana Pereira and {Da Silva}, {Vinicius Duval} and Felipe Zerwes and Deborah Raynes and Vincent Guerriero and Cristina Bonorino",
year = "2009",
month = "5",
doi = "10.1007/s12192-008-0085-6",
language = "English (US)",
volume = "14",
pages = "301--310",
journal = "Cell Stress and Chaperones",
issn = "1355-8145",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness

AU - Souza, Ana Paula

AU - Albuquerque, Caroline

AU - Torronteguy, Carolina

AU - Frasson, Antonio

AU - Maito, Fabio

AU - Pereira, Luciana

AU - Da Silva, Vinicius Duval

AU - Zerwes, Felipe

AU - Raynes, Deborah

AU - Guerriero, Vincent

AU - Bonorino, Cristina

PY - 2009/5

Y1 - 2009/5

N2 - HspBP1 is a co-chaperone that binds to and regulates the chaperone Hsp70 (Hsp70 is used to refer to HSPA1A and HSPA1B). Hsp70 is known to be elevated in breast tumor tissue, therefore the purpose of these studies was to quantify the expression of HspBP1 in primary breast tumors and in serum of these patients with a follow-up analysis after 6 to 7 years. Levels of HspBP1, Hsp70, and anti-HspBP1 antibodies in sera of breast cancer patients and healthy individuals were measured by enzyme-linked immunosorbent assay. Expression of HspBP1 was quantified from biopsies of tumor and normal breast tissue by Western blot analysis. The data obtained were analyzed for association with tumor aggressiveness markers and with patient outcome. The levels of HspBP1 and Hsp70 were significantly higher in sera of patients compared to sera of healthy individuals. HspBP1 antibodies did not differ significantly between groups. HspBP1 levels were significantly higher in tumor (14.46 ng/μg protein, n=51) compared to normal adjacent tissue (3.17 ng/μg protein, n= 41, p<0.001). Expression of HspBP1 was significantly lower in patients with lymph node metastasis and positive for estrogen receptora. HspBP1 levels were also significantly lower in patients with a higher incidence of metastasis and death following a 6 to 7-year follow-up. The HspBP1/Hsp70 molar ratio was not associated with the prognostic markers analyzed. Our results indicate that low HspBP1 expression could be a candidate tumor aggressiveness marker.

AB - HspBP1 is a co-chaperone that binds to and regulates the chaperone Hsp70 (Hsp70 is used to refer to HSPA1A and HSPA1B). Hsp70 is known to be elevated in breast tumor tissue, therefore the purpose of these studies was to quantify the expression of HspBP1 in primary breast tumors and in serum of these patients with a follow-up analysis after 6 to 7 years. Levels of HspBP1, Hsp70, and anti-HspBP1 antibodies in sera of breast cancer patients and healthy individuals were measured by enzyme-linked immunosorbent assay. Expression of HspBP1 was quantified from biopsies of tumor and normal breast tissue by Western blot analysis. The data obtained were analyzed for association with tumor aggressiveness markers and with patient outcome. The levels of HspBP1 and Hsp70 were significantly higher in sera of patients compared to sera of healthy individuals. HspBP1 antibodies did not differ significantly between groups. HspBP1 levels were significantly higher in tumor (14.46 ng/μg protein, n=51) compared to normal adjacent tissue (3.17 ng/μg protein, n= 41, p<0.001). Expression of HspBP1 was significantly lower in patients with lymph node metastasis and positive for estrogen receptora. HspBP1 levels were also significantly lower in patients with a higher incidence of metastasis and death following a 6 to 7-year follow-up. The HspBP1/Hsp70 molar ratio was not associated with the prognostic markers analyzed. Our results indicate that low HspBP1 expression could be a candidate tumor aggressiveness marker.

KW - Breast cancer

KW - Co-chaperone

KW - Hsp70

KW - Hspbp1

KW - Prognostic markers

UR - http://www.scopus.com/inward/record.url?scp=66149150652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149150652&partnerID=8YFLogxK

U2 - 10.1007/s12192-008-0085-6

DO - 10.1007/s12192-008-0085-6

M3 - Article

C2 - 18987994

AN - SCOPUS:66149150652

VL - 14

SP - 301

EP - 310

JO - Cell Stress and Chaperones

JF - Cell Stress and Chaperones

SN - 1355-8145

IS - 3

ER -